Vanguard Portfolio Management
MED icon

Vanguard Portfolio Management’s Medifast MED Stock Holding History

Vanguard Portfolio Management’s Portfolio MED Stock Details MED Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$309K Sell
29,108
-173,721
-86% -$2M ﹤0.01% 3095
2026
Q1 		$2.07M Buy
+202,829
New +$2.19M ﹤0.01% 2591

Other funds holding MED

Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
SCP
Steamboat Capital Partners Rye, New York $468M AUM 80.81% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Charles Schwab
Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Vanguard Portfolio Management's MED Position: Q2 2026 in Review

Vanguard Portfolio Management reduced its Medifast (MED) stake by 86% in Q2 2026, selling an estimated $2M and leaving 29,108 shares worth $309K. The position accounts for ﹤0.01% of the portfolio, ranked #3095.

Vanguard Portfolio Management first reported a position in MED in Q1 2026 and has held it in 2 quarters since. The position peaked at $2.07M in Q1 2026. 111 funds tracked by Wall St. Rank hold MED as of Q2 2026.

  • Vanguard Portfolio Management held 29,108 shares of Medifast worth $309K as of Q2 2026.
  • Vanguard Portfolio Management sold 173,721 Medifast shares in Q2 2026, an estimated $2M.
  • Medifast made up ﹤0.01% of Vanguard Portfolio Management's portfolio in Q2 2026, its #3095 holding.
  • Vanguard Portfolio Management first reported a position in Medifast in Q1 2026 and has held it in 2 quarters since.
  • Vanguard Portfolio Management's Medifast position peaked at $2.07M in Q1 2026.
  • 111 funds tracked by Wall St. Rank held Medifast as of Q2 2026.

Based on Vanguard Portfolio Management's 13F filing for Q2 2026, filed 13 Aug 2026.